The hCG␤ gene family contains six genes linked in tandem on chromosome 19 and labeled ␤ genes 7, 8, 5, 1, 2, and 3. Previous studies on a small number of placentas have indicated that ␤ gene 5 was the most highly expressed gene during the first trimester of pregnancy, followed by genes 3 and 8. ␤ genes 7, 1, and 2 were expressed at very low levels. The purpose of this study was to determine 1) whether this pattern of expression was typical during normal pregnancy by sampling a large number of first trimester placentas, and 2) whether there was a correlation between gestational age and the pattern of hCG␤ gene expression. Total RNA from 27 first trimester placentas varying in age from 6 -16 weeks was reverse transcribed into complementary DNA. The complementary DNA was amplified by PCR, and the amount of DNA representative of each hCG␤ gene was quantified by Genescan analysis. In 14 of the 27 placentas, hCG␤ gene 5 accounted for 50% or more of the total ␤ messenger RNA expressed. ␤ gene 3 was expressed at levels ranging from 1-42% of the total, and ␤ gene 8 expression ranged from 12-32% of the total. Gene 7 expression was less than 3% of the total ␤ expression in all 27 placentas. Although there appeared to be a trend toward lower expression of ␤ gene 3 in placentas beyond 10 weeks gestational age, there was no correlation of the pattern of ␤ expression with placental age. ␤ gene expression was also examined in two blighted ova, a spontaneous abortion sample, and a hydatidiform mole as well as in cultured JAR choriocarcinoma cells. With the exception of JAR cells, these abnormal tissues had low levels of gene 3 expression, but these levels were within the range of the patterns observed in normal placentas. These data suggest that it is the total amount of hCG␤ gene expression rather than the expression of individual ␤ genes that is important for the maintenance of normal pregnancy. (Endocrinology 138: 5459 -5465, 1997 H CG IS A heterodimeric glycoprotein hormone composed of noncovalently linked ␣-and ␤-subunits. It is a member of a family of related glycoprotein hormones that includes FSH, LH, and TSH. These hormones share a common ␣-subunit, but contain unique ␤-subunits that define their biological specificity. hCG is secreted in high quantity by the trophoblastic cells of the placenta during the first 12-14 weeks of pregnancy. The primary role of hCG is to stimulate the corpus luteum to secrete progesterone to maintain pregnancy.
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There are 6 homologous hCG␤ genes located in tandem repeat on chromosome 19q13.3 along with the LH␤ gene (1) (2) (3) . A previous study of a first trimester placenta showed that all 6 hCG␤ genes were expressed; however, 3 were expressed at much higher levels than the others (2) . hCG␤ gene 5 was found to account for 64% of the total hCG␤ expression. Genes 3 and 8 were each responsible for 18% of the total expression, and hCG␤ gene 7 accounted for less than 2% of the total expression. Genes 1 and 2 were also detected, but at levels of less than 1% of the total. In our study, we examined 27 placentas from 6 -16 weeks gestational age to determine whether this pattern of hCG␤ expression was typical of a normal pregnancy and whether the expression pattern varied with gestational age.
hCG␤ apparently evolved from gene duplication events of the LH␤ gene. Although the nucleotide sequences of hCG␤ and LH␤ are 94% homologous (4), at the amino acid level there is 85% homology between hCG␤ and LH␤ over the first 114 of 121 amino acids of LH␤ (5) . There are slight differences in the promoter regions of the genes, which may account for their differential tissue expression, i.e. LH␤ expression in the pituitary and hCG␤ expression in the placenta.
Genes 5, 3, and 8 give rise to identical proteins. The gene 7 product differs by one amino acid from the others, a Pro to Met at codon 4 (3). Genes 1 and 2, due to 5Ј-splice differences, give rise to unique open reading frames that may result in proteins with functions different from those of the other hCG␤ gene proteins (2) . There are also differences among the individual hCG␤ genes in the promoter regions that may play a role in the differences in expression among these genes. We were interested in determining whether the individual hCG␤ genes were up-or down-regulated during developmental stages in early pregnancy, perhaps yielding an expression pattern unique to each phase of early embryo growth. To begin to answer this question, we obtained placentas of various gestational ages and screened for hCG␤ expression of genes 5, 3, 8, and 7. It is also possible that unusual hCG␤ expression patterns play a role in the etiology of some clinical conditions, or that they could serve as unique biochemical markers in such cases as spontaneous abortion, blighted ovum, hydatidiform mole, choriocarcinoma, or ectopic hCG-producing cancers. For example, bladder cancers were recently found to produce hCG␤, and the level of hCG␤ gene expression from genes 5, 3, and 8 correlated with the stage of the tumor (6) . Transcription levels of these three hCG␤ genes increased with the stage of disease, whereas only ␤ gene 7 was expressed in normal urothelial tissue (6) .
In the study reported here, the levels of expression of ␤ genes 5, 3, 8, and 7 were examined in 27 normal placentas of 6 -16 weeks gestational age as well as in tissue samples obtained from spontaneous abortion, blighted ova, hydatidiform mole, and cultured JAR choriocarcinoma cells. In most of the normal placentas, gene 5 was the most highly transcribed gene, but there was significant variation in the percentage that gene 5 contributed to the total hCG␤ gene transcription. There were also highly variable contributions of genes 3 and 8 to the total amount of hCG␤ messenger RNA (mRNA) produced. Moreover, although the overall patterns of hCG␤ gene expression varied among the normal placentas, there was no correlation with gestational age. The pattern of expression among the abnormal tissues was not unique and was also seen in 1 or more of the normal placentas. These data suggest that a functional level of hCG␤ subunit can be obtained by expression of various ␤ genes and that it is the total level of hCG␤ produced rather than the expression of individual ␤ genes that is important for maintenance of early pregnancy.
Materials and Methods

RNA isolation
Twenty-seven normal placenta samples were obtained from patients of the Women's Services Clinic Professional Corporation (Omaha, NE) in accordance with protocols approved previously by the University of Nebraska Medical Center internal review board (080 -95-EX). Case histories were obtained, and the placentas were examined for abnormal structure by gross inspection and by histopathology. The 27 placentas used for this study were all deemed to be normal. Two spontaneously aborted placentas, 1 hydatidiform mole specimen, and 2 implanted blighted ovum tissues were obtained from patients of the University of Nebraska Medical Center according to internal review board 348 -93 specifications. JAR cells were cultured in DMEM to confluence. Tissues or cells were disrupted with TRIzol Reagent (Life Technologies, Grand Island, NY) and a Polytron homogenizer (Brinkmann Instruments, Westbury, NY). Total RNA was isolated from 50 -100 mg tissue homogenized in 1 ml TRIzol. Chloroform (200 l) was added, and samples were shaken for 15 sec, incubated at 21 C for 3 min, and then centrifuged at 12,000 ϫ g for 15 min. The clear aqueous phase was transferred into 0.5 ml sterile isopropanol and incubated at 21 C for 10 min, then centrifuged for 10 min. The alcohol was removed from the pellet, and the RNA was washed once with 1 ml sterile 75% ethanol. The pellet was allowed to air-dry for approximately 5 min and then was resuspended in 50 -100 l diethyl pyrocarbonate-treated water.
RT-PCR
The RNA PCR strategy and subsequent Genescan analysis were adapted and modified slightly from the methods of Lazar et al. (6) . Contaminating DNA was digested away from the total RNA with ribonuclease-free deoxyribonuclease I, and the resulting products were quantified by measuring absorption at 260/280 nm ratios. The first strand complementary DNA (cDNA) was synthesized from 1 g total RNA isolated from tissue, with Superscript II (Life Technologies) at a final concentration of 2.5 U in the Life Technologies first strand buffer containing 25 mm Tris-HCl (pH 8.3), 37.5 mm KCl, 4 mm MgCl 2 , 4 mm dithiothreitol, 0.5 mm of each deoxy-NTP, and 2.5 m of random hexamers. Incubation was performed at 42 C for 50 min, followed by 70 C for 15 min. RNA was then digested with ribonuclease H at 37 C for 20 min. The PCR reaction mixture totaled 50 l and consisted of 5 l first strand reaction product, 2.5 U Taq polymerase (Life Technologies), and PCR buffer solution (Life Technologies) containing 20 mm Tris-HCl (pH 8.4), 50 mm KCl, 1 mm MgCl 2 , 0.2 mm of each deoxy-NTP, and 10 pmol of each of the hCG␤-directed ␤1 and ␤2 oligonucleotide primers or the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sense and antisense primers. Oligonucleotide primers were synthesized by the Eppley Institute Molecular Biology Core Laboratory on an Applied Biosystems (Foster City, CA) model 394 DNA/RNA synthesizer. hCG␤ oligonucleotides were designed ( Fig. 1 ) based on data from Lazar et al. (6) . Both ␤1 and ␤2 primers completely matched the flanking sequences of each of the hCG␤ genes 5, 3, 8, and 7, resulting in similar amplification efficiencies for the ␤ genes, amplifying them proportionally to their transcript ratios (7).
6-Carboxyfluorescein was incorporated into the 5Ј-end of the antisense primer, ␤2. GAPDH primers were designed using the published nucleotide sequence data from the human GAPDH gene (8) . Primer sequences are indicated in Fig. 1B . hCG␤ and GAPDH cDNA fragments were amplified from the cDNA templates in a Perkin-Elmer (Foster City, CA) model 2400 thermal cycler using a hot start of 94 C for 4 min, followed by 35 cycles of 94 C for 30 sec, 60 C for 30 sec, 72 C for 30 sec, and a final extension of 72 C for 7 min.
Genescan analysis
Fifteen microliters of the RT-PCR products with 7.5 l methyl green/ yellow food coloring-50% glycerol were electrophoresed on a 1% (wt/ vol) agarose gel in Tris-glacial acetic acid-EDTA buffer. The gel contained 0.2 g/ml ethidium bromide to visualize the amplified hCG␤ and GAPDH amplicons. The hCG␤ RT-PCR products (17.25 l) were digested with 2.5 U DraI and 5 U HhaI (New England Biolabs, Beverley, MA). Figure 1A illustrates the mRNA structures of the four hCG␤ genes under examination and the locations of the ␤ primers. DraI and HhaI restriction sites are labeled, and resulting size fragments are indicated. Digested DNA fragments were then coelectrophoresed with the Genescan 500 6-carboxy-X-rhodamine (ROX) size standards on a denaturing 6% acrylamide gel run on a 373 ABI sequencing apparatus by the Eppley Institute Molecular Biology Core Laboratory. The gel was analyzed by 672 Genescan software, which determines the length of the fragments in each lane, calculates the intensity of the 6-carboxyfluorescein dye in the ␤2 primer, and expresses the absorbance intensity in relative fluorescence units. The data are then expressed as an electrophoretogram displaying the gel DNA bands as peaks that illustrate the intensity of the dye-labeled primer for each hCG␤ gene in terms of peak height and area.
Results
hCG␤ genes 5, 3, 8, and 7 from normal placentas were amplified with primers ␤1 and ␤2 to yield a 423-bp product (Fig. 1A ). These PCR products were then digested with restriction enzymes DraI and HhaI, which gave different sized fragments for each gene: ␤5, 341 bp; ␤3, 360 bp; ␤8, 233 bp; and ␤7, 391 bp (Fig. 1A) . The smaller restriction products were not seen because only the ␤2 primer, incorporated into each large restriction product, was fluorescein labeled. The bands on the 6% acrylamide gel were converted to peaks by the Genescan 672 analysis software, and the fluorescent peak intensity was calculated for each gene.
Examples of some of the different types of gene expression patterns are illustrated in Genescan electrophoretograms in Figure  2D has a unique peak at approximately 45 bp that is probably a primer dimer or a nonspecific amplification artifact in this particular sample. To control for possible genomic DNA contamination of RNA, samples were also run without Superscript reverse transcriptase, and no amplification of hCG␤ was detected by Genescan analysis (Fig. 2E) . The small peaks detected in this panel are the Genescan 500 ROX internal lane size standards.
Primers were designed to amplify the housekeeping gene GAPDH (8) for use with RT-PCR to show that similar amounts of GAPDH cDNA were being amplified in each sample and that the RNA was of good quality (Fig. 3) .
Twenty-seven normal placental samples ranging from 6 -16 weeks of age were analyzed in this manner. Eleven of the 27 normal placental samples displayed the hCG␤ gene expression pattern previously identified by Bo et al. (2) in that the order of high to low expression was 5 Ͼ 3 ϭ 8 Ͼ Ͼ 7. However, the percent expression of each ␤ gene described by Bo et al. was 64:18:18 for genes 5, 3, and 8, respectively, whereas in our study of the 11 samples showing a similar pattern, gene 5 was responsible for between 40 -60% of the total hCG␤ expression, and genes 3 and 8 were responsible for between 20 -30% each. Several samples displayed other unique hCG␤ expression patterns: 5 ϭ 3 Ͼ 8 Ͼ Ͼ 7 (n ϭ 5), 5 Ͼ 8 Ͼ 3 ϭ 7 (n ϭ 5), and 5 ϭ 3 ϭ 8 Ͼ Ͼ 7 (n ϭ 4). Two other expression patterns were detected in low frequency, 5 Ͼ 3 Ͼ 8 Ͼ Ͼ 7 (n ϭ 1) and 5 ϭ 8 Ͼ 3 Ͼ Ͼ 7 (n ϭ 1). In all cases, gene 7 was only responsible for approximately 1-2% of the hCG␤ expression, except in one 8-week-old specimen in which gene 7 was undetectable. hCG␤ gene expression of genes 5, 3, 8, and 7 from all 27 placentas is plotted in Fig. 4 . The mean percent expression for genes 5, 3, 8, and 7 and the sd for each are shown in Table 1 for each of the 27 placentas.
An oligonucleotide of sequence 5Ј-ATCTGAGAGAGAG-CAGCCA-3Ј was designed for PCR with the ␤2 primer to examine expression of hCG␤ genes 1 and 2 in several of the normal, first trimester placentas. RT-PCR was performed as described above for primers ␤1 and ␤2. Concentrated products were then examined by Genescan analysis (data not shown). A 399-bp product was visualized in half of the specimens examined; however, the signal was below the level of nonspecific background PCR products. A 13-week-old specimen displaying 80% of total ␤ expression due to gene 5 was diluted 1:50 with water, and the fluorescent intensity was barely detectable (data not shown); therefore, we conclude that genes 1 and 2 are expressed in a quantity less than 1/50th the amount of gene 5.
Several other tissues from different clinical conditions, such as hydatidiform mole, blighted ovum, and spontaneous abortion, were analyzed to determine their hCG␤ gene expression (Fig. 5) . The hydatidiform mole displayed hCG␤ gene expression pattern 5 Ͼ 8 Ͼ Ͼ 3 ϭ 7. Two blighted ovum specimens were analyzed and found to display a 5 Ͼ 8 Ͼ Ͼ 3 Ն 7 pattern of hCG␤ gene expression. Although these samples showed low levels of gene 3, the levels were within the range of expression observed in the normal placentas. It may be noteworthy that in one of the blighted ovum samples, hCG␤ gene 7 was responsible for 6% of total hCG␤ expression. This was the highest gene 7 expression detected in any of the samples we examined. The spontaneously aborted placenta also had a normal pattern of gene expression: 5 Ͼ 3 ϭ 8 Ͼ Ͼ 7. The JAR choriocarcinoma cell line was also analyzed to determine which hCG␤ genes were transcribed, and a gene expression pattern of 3 Ͼ 5 Ͼ 8 Ͼ Ͼ 7 was detected (Fig. 5) . Although JAR cells expressed a higher percentage of total expression from gene 3 and a lower percentage from gene 5 than was seen in most of the normal placentas, the expression pattern, 5 ϭ 3 Ͼ 8 Ͼ Ͼ 7, was not unusual. The mean percent expression for genes 5, 3, 8, and 7 and the sd for each of the clinical specimens are shown in Table 1 . 
Discussion
The purposes of this study were to characterize hCG␤ gene expression in a number of normal placentas to determine which genes are expressed during normal pregnancy and to determine whether there was evidence of hCG␤ gene switching with increasing gestational age. To carry out this study, we used the methods of Lazar et al. (6) , which employed RT-PCR followed by restriction enzyme digestion and Genescan analysis of hCG␤ genes 5, 3, 8, and 7 in each sample.
Our results indicate that normal placentas express genes 5, 3, and 8 in amounts detectable by RT-PCR. However, the expression levels of each gene seem to vary among individuals. In all placentas, hCG␤ gene 5 was highly expressed, ranging from 35-82% of the total hCG␤, but in many cases genes 3 and 8 were also responsible for high levels of expression. Transcription of gene 3 was quite variable, ranging from 1-42% of the total ␤ gene expression. In two placental samples, gene 3 accounted for only 1-2% of the hCG␤ expression, whereas in 17 samples it accounted for 25% or less of the ␤ gene transcript. Gene 8 transcription varied from 12-32% of the total. Gene 7 was also transcribed in detectable levels, except in one 8-week-old tissue specimen that displayed no gene 7 transcript. These data indicate that there is heterogeneity in the levels of expression of each gene in individual placentas. Thus, it appears that the important factor during the first trimester of pregnancy is the total amount of hCG␤ gene transcription and not necessarily from which gene the mRNA is derived. As the amount of hCG␤ protein during pregnancy is regulated at the transcriptional level (9), it is likely that the amount of ␤ gene transcripts correlates with the amount of hCG␤ protein in the placentas examined in this study. We were also interested in determining whether the six hCG␤ genes were being up-or down-regulated with increasing gestational age. No clear pattern of ␤ gene transcription could be correlated with placental age. The later age placentas appear to have the same heterogeneous gene expression as the earlier age placentas. There does, however, appear to be a slight shift in regulation of hCG␤ gene 3 as gestational age increases. Some samples of 11 weeks or older showed very low levels of gene 3 expression, and this was not detected in any of the 6-to 10-week-old placentas. More placentas would need to be analyzed to confirm this as a normal event during pregnancy.
To investigate the question of whether atypical patterns of hCG␤ gene expression occur in some disease states, specimens from the JAR choriocarcinoma cell line, hydatidiform mole, blighted ovum, and spontaneous abortion tissues were examined. These data were then compared with the normal pregnancy data. The hydatidiform mole is a gestational trophoblastic tumor that originates from placental tissue (10) . Blighted ovum pregnancies are those that do not develop a fetal pole for unknown reasons (11) . If these specimens were to display unusual patterns of hCG␤ gene expression, then analysis of these patterns could have diagnostic significance.
For example, if hCG␤ gene expression and tumor stage could be correlated for hCG-producing malignancies, then analysis of surgical or biopsy samples could be used to predict prognosis or response to therapy. Similarly, ␤ gene expression patterns in abortuses might reveal some defect in gene expression in individuals experiencing frequent spontaneous abortions. However, none of the abnormal specimens examined had a pattern of ␤ gene transcription outside of the variation seen in normal placentas. Further studies on a larger number of specimens need to be conducted to determine whether unusual hCG␤ gene expression correlates with a particular clinical condition.
There are several possible explanations for the differential expression of the hCG␤ genes in individuals. First, the nucleotide sequence differences among the promoters for each of the four hCG␤ genes appear be in areas that make them stronger or weaker promoters (12) . Chimeras formed by adding either a portion of the gene 7 promoter to gene 5, or the gene 5 promoter to gene 7 display no activity or full activity, respectively, when transfected into Y1 cells (12) . This suggests that it is the nucleotide differences in the promoter region from MstII (Ϫ187) and SpeI (ϩ103) that are partially responsible for the disparity in transcription levels (12) . A number of putative transcription factor-binding sites have been identified in this region of the hCG␤ promoters. There are two cAMP regulatory element-binding sites (13, 14) , three to four trophoblast-specific element (TSE)-binding sites that would aid in activation of the hCG␤ genes (15) , and an Oct 3/4-binding site that is probably involved in repression of hCG␤ gene transcription in during early stages of pregnancy (16) . There are two putative Sp-1-binding sites with the sequence GGGAGG in this portion of the proximal promoter region of gene 5. Sp-1 is hypothesized to play a role as a tether to anchor basal transcription factors in the initiation complex of TATA-less promoters, such as hCG␤ (4, 17) . The hCG␤ genes differ in their nucleotide sequences in these regions, and perhaps this is the cause of the differential expression among the genes. For example, hCG␤ 7 differs by three nucleotides from gene 5 in the first two TSE-binding sites. The only other differences in binding site regions occur in the Sp-1 sites. As the TSE regions are believed to be only weak activators of the hCG␤ genes, it may be the changes in the Sp-1 sites that are important for transcription. If these binding sites are indeed used by transcription factors in vivo, then it may be possible that these base changes are responsible for the differential expression of these genes. Mutational analysis experiments have been performed in some of these potentially critical areas. For example, by mutating wild-type hCG␤ gene 5 from GG at Ϫ55 and Ϫ54 to TT, which is the native sequence for gene 7, transcription is down-regulated 5-fold (17) . Other unique polymorphisms may exist in the population in these regions that also play roles in differential expression of the hCG␤ genes. Polymorphisms may create better or worse recognition binding sites for the transcription factors, resulting in unique levels of expression in individuals. There is also a distal promoter region (Ϫ3700 to Ϫ1700) upstream from the proximal promoter in the hCG␤ genes that plays a role in the expression of the ␤ genes. Deletion mutants in this region have been shown to affect hCG␤ basal transcription (1, 4) . Nucleotide changes in these distal promoter regions may also change the amount of expression among individuals. Another possible reason for the differential hCG␤ expression among individuals is that differences in methylation can up-or down-regulate transcription of particular hCG␤ genes, and perhaps different individuals have unique amounts of methylation in the promoter regions of these genes. It will be of interest to examine a random population of people to gain information on the polymorphisms that exist in the promoter regions and to examine them for methylation differences.
